Showing results (221-230 of 271) with videos related to

Sort By:
Pageof 28
Microbiome|October 16, 2023
Antimicrobial peptides modulate lung injury by altering the intestinal microbiotaAhmed Abdelgawad, Teodora Nicola, Isaac Martin, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Antimicrobial peptides modulate lung injury by altering the intestinal microbiotaAhmed Abdelgawad, Teodora Nicola, Isaac Martin, et al.
BMJ Open|July 12, 2022
Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa studyMichihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.
Hepatology Communications|October 30, 2023
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver diseaseMichihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.
Epilepsia|November 19, 2016
Increased subcortical oligodendroglia-like cells in pharmacoresistant focal epilepsy in children correlate with extensive epileptogenic zonesSatoru Sakuma, William C Halliday, Ruka Nomura, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|September 16, 2021
Cytomegalovirus-related sepsis-like syndrome in very premature infants in JapanFumihiko Namba, Ryota Nakagawa, Mitsuhiro Haga, et al.
Journal of Neurogastroenterology and Motility|April 9, 2026
Therapeutic Impact on Quality of Life in Adult Patients With Chronic Intestinal Pseudo-obstruction: A Multicenter, Cohort StudyKota Takahashi, Takaomi Kessoku, Hidenori Ohkubo, et al.
Clinical Genitourinary Cancer|December 3, 2014
Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancerAtsushi Kanatani, Tohru Nakagawa, Taketo Kawai, et al.
Clinical Transplantation|March 28, 2022
Two-year outcomes of low-exposure extended-release tacrolimus and mycophenolate mofetil regimen in de novo kidney transplantation: A multi-center randomized controlled trialYuji Hidaka, Norihiko Goto, Shigeyoshi Yamanaga, et al.
Bioscience of Microbiota, Food and Health|April 2, 2024
Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trialHidenori Ohkubo, Takaomi Kessoku, Kosuke Tanaka, et al.
Pageof 28